We established a hiPSC line derived from a female patient carrying a heterozygous R302Q mutation in HTRA1 with clinical manifestations of CSVD such as stroke, dementia, multiple lacunar infarcts, and cervical spondylosis. The gene discussed is HTRA1; the disease is infarction.